Skip to main content

Table 2 Cytogenetic findings in AML patients and their distribution according to risk stratification (n = 29)

From: Wilms tumor 1 gene expression in acute myeloid leukemia: prognostic significance and usefulness in minimal residual disease monitoring—a case–control study

Risk group according to cytogenetics Cytogenetics Number Percentage (%)
High risk group (n = 3) Unfavorable cytogenetics   
inv.3 1 3.5
t (6;9) 2 6.9
Intermediate risk group (n = 22) Intermediate cytogenetics   
Cytogenetic abnormality not classified as adverse or favorable 8 27.5
Normal karyotype 14 48.3
Low risk group (n = 4) Favorable cytogenetics   
t (8; 21) 2 6.9
t (15; 17) 2 6.9
Total   29 100